Eldepryl
Eldepryl
- In our pharmacy you can buy eldepryl without a prescription, with delivery in 5–14 days throughout the United Kingdom. Discreet and anonymous packaging.
- Eldepryl (selegiline) is used mainly in Parkinson’s disease as an adjunct to levodopa; it is a selective monoamine oxidase B (MAO‑B) inhibitor that increases central dopamine levels by reducing dopamine breakdown.
- The usual dose for Parkinson’s is 5–10 mg daily (commonly 5 mg twice daily) for tablets/capsules; orally disintegrating tablets (Zelapar) are typically 1.25–2.5 mg once daily; transdermal patches (Emsam) are dosed 6–12 mg/24 hr for depressive indications rather than as Eldepryl.
- Administration is oral (tablets or capsules), orally disintegrating tablet (ODT) formulations, or transdermal patch for the patch product.
- Some patients may notice effects within hours (ODT formulations can be absorbed faster, e.g. 30–60 minutes), but meaningful clinical improvement in motor symptoms usually develops over days to weeks.
- The symptomatic duration is typically around 24 hours per dose; MAO‑B inhibition can persist longer (enzyme activity recovery may take days to a week or more) because the inhibition is irreversible.
- Avoid alcohol or use with caution; alcohol may worsen dizziness and orthostatic effects and, combined with tyramine‑rich foods or interacting drugs, increases the risk of hypertensive reactions—particularly at higher doses or with nonselective MAOI use.
- The most common side effect is nausea (other frequent effects include dry mouth, dizziness, insomnia, headache and increased sweating).
- Would you like to try eldepryl without a prescription?
Eldepryl
Basic Eldepryl Information
- INN (International Nonproprietary Name): Selegiline (also known as Selegilina, Selegilinum, L-Deprenalin).
- Brand Names Available In United Kingdom: Eldepryl — tablets 5 mg and 10 mg, typically supplied in blister packs of 28 or 100.
- ATC Code: N04BD01 (Monoamine Oxidase B Inhibitors for Anti‑Parkinson Drugs).
- Forms & Dosages: Tablets 5 mg and 10 mg; capsules 5 mg; orally disintegrating tablet (Zelapar) 1.25 mg; transdermal patches (Emsam) 6, 9, 12 mg/24 hr.
- Manufacturers In United Kingdom: Sovereign Medical (local supplier noted in product listings).
- Registration Status In United Kingdom: Prescription only, MHRA-regulated and approved for use in Parkinson’s disease.
- OTC / Rx Classification: Prescription only (Rx) in the UK.
This is practical pharmacist-style guidance, not a replacement for clinical advice.
Eldepryl contains selegiline (INN: selegiline) and is prescription-only in the United Kingdom under MHRA regulation.
Keep tablets in their original blister packs and store below 25°C, away from moisture, light and children.
If you are prescribed Eldepryl alongside levodopa/carbidopa expect dose reviews and monitoring for blood pressure and mental state during follow-up.
Avoid taking other monoamine oxidase inhibitors, certain opioids, many SSRIs/SNRIs and very large amounts of tyramine-rich foods while on selegiline.
Overdose risks include severe hypertension, agitation, hallucinations and other life‑threatening complications — seek urgent medical care for suspected overdose.
Practical daily tips: set a dosing alarm, keep an up-to-date medicines list for NHS appointments and check with your GP or local Boots/LloydsPharmacy pharmacist before buying any new over-the-counter medicines.
Everyday Use & Best Practices
Morning Vs Evening Dosing
Patients often ask whether Eldepryl should be taken in the morning or evening.
Usual adult dosing is 5–10 mg daily, commonly given as 5 mg twice daily or as an orally disintegrating tablet once daily at 1.25–2.5 mg.
Many clinicians recommend a morning-first dosing approach to reduce the risk of insomnia.
If sleep disturbance occurs, taking the larger or single dose in the morning is commonly advised.
When selegiline is used with levodopa/carbidopa, coordinate timing to help manage wearing-off periods.
Taking With Or Without Meals (UK Diet Habits)
Selegiline absorption is not strongly affected by food, so it may be taken with or without food according to tolerance.
Heavier evening meals common in UK households can worsen sleep if the drug is taken late, so consider shifting doses earlier in the day if you notice insomnia.
If nausea happens, try taking Eldepryl with a light snack rather than a full meal.
Avoid grapefruit products and reduce excess caffeine if you experience dizziness or jitteriness.
- Morning Practical Steps: take dose with breakfast, set an alarm and note dose on your repeat prescription list.
- Evening Practical Steps: if you must dose later, choose earlier evening and avoid stimulants before bed.
Missed-dose checklist: take the missed dose as soon as you remember unless the next dose is due soon; do not double the dose.
Safety Priorities
Who Should Avoid It (MHRA Warnings)
Absolute contraindications include known hypersensitivity to selegiline or its excipients, and concurrent use with other MAOIs, certain opioids such as meperidine, or serotonergic agents.
Pheochromocytoma is also an absolute contraindication because of hypertensive crisis risk.
Patients with severe cardiovascular disease, marked hypertension or unstable arrhythmias require specialist review before starting selegiline.
People with current psychosis, mania or severe mental‑status disorders need careful assessment due to risk of worsening symptoms.
Activities To Limit (Driving, Work Safety)
Selegiline can cause dizziness, orthostatic hypotension and occasionally sudden sleepiness, so caution is required when driving or operating heavy machinery.
UK DVLA rules require drivers to report medication-caused dizziness or sudden loss of awareness; follow your GP’s advice about driving fitness.
- Red Flags To Act On: chest pain, sudden severe headache, very high blood pressure, sudden confusion or hallucinations — seek urgent medical help.
- Report Adverse Events: use the MHRA Yellow Card scheme; community pharmacists at Boots, LloydsPharmacy and Superdrug can assist with reporting.
Below is a brief table of drug classes commonly contraindicated or requiring review while taking selegiline.
| Drug Class | Action |
|---|---|
| Other MAOIs | Contraindicated |
| Serotonergic Antidepressants (SSRIs/SNRIs) | Strong caution; specialist may require washout |
| Certain Opioids (e.g. Meperidine) | Contraindicated |
| Sympathomimetics | Avoid or monitor closely |
Dosage & Adjustments
General Regimen (NHS Guidance)
Standard adult dosing for Parkinson’s disease is 5–10 mg daily, most often as 5 mg twice daily for tablet/capsule formulations.
Zelapar ODTs are available at 1.25 mg and may be used once daily in some regimens.
NHS practice typically starts at the lower end of the dose range and reviews response and side effects after four to six weeks.
When used with levodopa/carbidopa, doses are adjusted to reduce wearing-off and to aim for the best balance between mobility and adverse effects.
Special Cases (Elderly, Comorbidities)
Elderly patients should generally start low and increase slowly because of increased sensitivity and greater polypharmacy risk.
Monitor orthostatic blood pressure and cognitive status closely in older adults as dizziness and hallucinations are more likely with multiple medicines.
Use caution and closer monitoring in patients with significant liver or renal impairment due to possible reduced clearance.
Selegiline is not recommended in children; paediatric dosing is not established.
| Form | Usual Dose | Monitoring |
|---|---|---|
| Tablet/Capsule | 5–10 mg daily (often 5 mg twice daily) | BP, mood, sleep |
| ODT (Zelapar) | 1.25–2.5 mg once daily | GI tolerance, insomnia |
User Testimonials
Positive Reports From UK Patients
Many UK patients report clearer "on" periods and a slowdown in needing higher levodopa doses after starting selegiline.
Common positive themes include improved morning mobility and reduced daytime stiffness for some people.
Patients frequently note a small levodopa‑sparing effect when selegiline is introduced early as an adjunct.
Common Challenges (Patient.info, NHS Forums)
Typical challenges reported on Patient.info and NHS forums include sleep disturbance when dosing is late and occasional dizziness or orthostatic symptoms.
Some patients discover drug interactions during medication reviews and need prescriber adjustments.
NHS prescription logistics are a frequent topic: arranging repeat prescriptions via the GP or pharmacy collection at Boots or LloydsPharmacy is routine, and prescription costs vary across the UK.
- Patient Pros: better "on" time, modest levodopa reduction, tolerable mild side effects like dry mouth.
- Patient Cons: insomnia if taken late, dizziness, administrative delays with repeat prescriptions.
Checklist for GP/pharmacist discussion: report new sleep problems, dizziness, unexpected mood changes and any OTC or herbal products you use.
Buying Guide
Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)
Eldepryl is prescription-only in the UK and is dispensed through community pharmacies such as Boots, LloydsPharmacy and Superdrug, as well as hospital pharmacies.
Registered online UK pharmacies can supply selegiline only on presentation of a valid prescription.
Check MHRA status and pharmacy registration before ordering and avoid unlicensed imports without MHRA confirmation.
Price Comparison (NHS Prescription Charge Vs Private)
In England a prescription charge applies per item; prescriptions are free in Scotland, Wales and Northern Ireland.
Private-pay patients should compare pharmacy dispensing fees and branded vs generic costs when choosing where to collect their medicine.
Typical packaging for tablets is 5 mg and 10 mg in blisters of 28 or 100.
In our online pharmacy, eldepryl is available with a valid prescription, with discreet delivery to United Kingdom in 5-14 days.
| Source | Typical Packaging | What To Ask Your Pharmacist |
|---|---|---|
| Boots / LloydsPharmacy / Superdrug | Tablets 5 mg / 10 mg in 28 or 100 blisters | Brand, storage, side effects |
| Hospital Pharmacy | Prescribed supply | Specialist dosing questions |
| UK Registered Online Pharmacy | As above | Check registration, prescription requirements |
What’s Inside & How It Works
Ingredients Overview
The active ingredient is selegiline (INN: selegiline).
Formulations sold include tablets (5 mg, 10 mg), capsules (5 mg), orally disintegrating tablets (Zelapar 1.25 mg) and transdermal patches marketed as Emsam in other markets.
Excipients vary by manufacturer, so always read the patient information leaflet for possible allergens.
Mechanism Basics Explained Simply
Selegiline is a monoamine oxidase B (MAO-B) inhibitor that slows the breakdown of dopamine in the brain.
By preserving dopamine levels, it can modestly improve motor symptoms and may allow lower levodopa doses for some time.
At higher doses selectivity for MAO-B may diminish, increasing interaction risk with tyramine-containing foods and certain medicines.
- What It Does: reduces dopamine breakdown, improves motor function, delays levodopa escalation for some patients.
- What To Monitor: mood, blood pressure, sleep and any signs of hallucination or severe agitation.
Main Indications
Approved Uses (MHRA Listing)
Selegiline (Eldepryl) is licensed as an adjunctive treatment in Parkinson’s disease to improve motor fluctuations and reduce levodopa wearing-off.
It is classified under ATC code N04BD01 as a dopaminergic antiparkinsonism agent.
Supply and use are regulated by the MHRA in the United Kingdom.
Off-Label Uses In UK Clinics
Transdermal selegiline patches are used elsewhere for depression, but tablet forms such as Eldepryl are primarily for Parkinson’s in the UK.
Neurologists may consider selegiline early in disease to delay levodopa escalation or in specific patients with levodopa-related fluctuations.
| Use | Licence Status |
|---|---|
| Adjunct In Parkinson’s Disease | Licensed |
| Depression (Transdermal) | Used elsewhere; not the primary licence for Eldepryl tablets |
Ask your prescriber about expected benefits, likely monitoring and potential interactions before starting treatment.
Interaction Warnings
Food Interactions (Alcohol, Tea/Coffee)
Selegiline is a selective MAO-B inhibitor at usual doses, which reduces but does not eliminate the risk from tyramine-rich foods.
Avoid very large amounts of aged cheese, cured meats and certain supplements to reduce hypertensive crisis risk.
Moderate tea or coffee is generally acceptable, but avoid excessive caffeine if you experience palpitations or anxiety.
Avoid excessive alcohol while monitoring for increased side effects.
Drug Conflicts (MHRA Yellow Card Reports)
Major interaction risks include other MAOIs, serotonergic antidepressants (SSRIs, SNRIs, triptans), certain opioids such as meperidine and sympathomimetics.
These combinations can precipitate serotonin syndrome or hypertensive crises and are therefore contraindicated or need specialist management.
- Contraindicated: other MAOIs, meperidine.
- Use With Caution: SSRIs/SNRIs, triptans, certain nasal decongestants, some anaesthetics.
Community pharmacists can flag potential conflicts during medication reviews and assist with Yellow Card reporting for suspected adverse drug reactions.
Latest Evidence & Insights
Key UK & EU Studies 2022–2025
Recent UK and EU literature has examined MAO-B inhibitors’ role in delaying levodopa escalation and managing motor fluctuations.
Comparative work with rasagiline and safinamide highlights differences in dosing convenience and safety profiles.
Randomised trials and observational registries report modest symptomatic benefits for selegiline but meaningful quality-of-life gains in selected subgroups, especially when introduced early as an adjunct.
Safety analyses continue to emphasise monitoring for interactions and blood pressure changes.
Practical Takeaways For Patients
- Discuss the timing of selegiline with your neurologist to see if it suits your stage of Parkinson’s.
- Carry a current medication list to each NHS appointment and include OTCs and herbal remedies.
- Expect periodic BP checks and medication reviews on the NHS after initiation.
Headline conclusions from recent reviews: efficacy is modest but clinically useful for some, safety requires vigilance, and alternatives may suit patient preferences for dosing frequency.
Alternative Choices
NHS Prescribing Alternatives With Pros/Cons Checklist
Alternatives on NHS formularies include rasagiline, safinamide and COMT inhibitors such as entacapone or tolcapone used alongside levodopa.
Rasagiline offers once-daily dosing and a modern safety record, while safinamide can help in more advanced fluctuation scenarios and has a reversible mechanism.
COMT inhibitors are focused on enhancing levodopa action but carry their own side-effect considerations.
- Rasagiline: once-daily convenience; similar MAO-B action.
- Safinamide: reversible MAO-B action; may help advanced fluctuations.
- COMT Inhibitors: reduce wearing-off by extending levodopa effect; monitor liver function for some agents.
When To Consider Switching
Consider switching if symptom control is inadequate, side effects such as severe insomnia or dizziness are intolerable, or if interactions make continued use unsafe.
Patient preference for once-daily dosing or adherence difficulties are valid reasons to discuss alternatives with your GP or neurologist.
Always coordinate changes through NHS pathways and expect a review before switching medications.
Regulation Snapshot
MHRA Approval & NHS Prescribing Framework
Selegiline (Eldepryl) is MHRA-approved and prescription-only in the United Kingdom.
Prescribing and dispensing follow NHS and general dental practice rules, local formularies and the product’s summary of product characteristics.
Common UK pack sizes include tablets 5 mg and 10 mg in blister packs of 28 or 100.
International Registration Notes (Packaging, ATC)
The ATC classification is N04BD01 for MAO-B inhibitors used in Parkinson’s disease.
International manufacturing and suppliers include Somerset Pharmaceuticals, Valeant (Zelapar), Mylan and global generics such as Sun Pharma and Teva, while Sovereign Medical is noted as a UK supplier.
Product labelling and licence details can vary internationally, so always consult the UK summary of product characteristics for local dosing and safety information.
| Licence Aspect | Notes |
|---|---|
| Regulator | MHRA in the United Kingdom |
| Pack Sizes | Tablets: 28 or 100; ODTs in blisters |
| ATC Code | N04BD01 |
FAQ Section
Will Eldepryl Interact With My Antidepressant?
Many SSRIs and SNRIs pose a risk of serotonin syndrome when combined with MAO inhibitors.
Always tell your GP if you are on an antidepressant; a specialist may advise a washout period before starting selegiline or choose a safer alternative.
What To Do About Sleep Problems Or Dizziness?
If you experience insomnia, try moving doses to the morning and avoid late doses.
For dizziness or orthostatic symptoms, rise slowly from sitting and report symptoms to your pharmacist or GP for possible dose adjustment.
Your pharmacist can suggest non-prescription strategies and liaise with your prescriber when required.
Can I Drink Tea/Coffee Or Alcohol?
Moderate tea and coffee are usually acceptable, but avoid excessive caffeine if you feel palpitations or anxiety.
Avoid excessive alcohol and large amounts of tyramine-rich foods while on selegiline.
How Are Repeat Prescriptions Managed?
Repeats are arranged via your GP practice or via pharmacy-managed repeat dispensing at Boots or LloydsPharmacy where available.
Check your NHS exemption status for prescription charges if you live in England; prescriptions are free in Scotland, Wales and Northern Ireland.
Immediate action checklist: stop and seek emergency care for severe headache, chest pain, very high blood pressure or sudden confusion.
Guidelines For Proper Use
UK Pharmacist Counselling Style
When dispensing, pharmacists should confirm the indication, review the full medication list including OTCs and supplements and check allergies.
Advise on the dosing schedule, storage below 25°C in the original blister pack, missed-dose instructions and common side effects such as nausea, dry mouth, insomnia and orthostatic hypotension.
Emphasise the need to consult before starting new prescription or non-prescription medicines and to report any worrying adverse effects promptly.
NHS Patient Support Advice
Encourage enrolment in repeat dispensing and provide Yellow Card reporting information for adverse events.
Signpost patients to Parkinson’s UK, local neurology clinics and NHS self-management resources for additional support.
Provide a one-page action plan covering when to call the GP or 999, a suggested monitoring schedule and contact points for pharmacy and specialist advice.
- Pharmacy Counselling Checklist: indication, meds list, allergies, dosing, storage, interactions, Yellow Card info.
- Patient Action Plan: when to seek help, BP checks, review appointments, emergency contacts.
Delivery Across United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | Greater London | 5-7 days |
| Birmingham | West Midlands | 5-7 days |
| Manchester | Greater Manchester | 5-7 days |
| Glasgow | Glasgow City | 5-7 days |
| Leeds | West Yorkshire | 5-7 days |
| Liverpool | Merseyside | 5-7 days |
| Edinburgh | City of Edinburgh | 5-7 days |
| Bristol | Somerset | 5-9 days |
| Newcastle Upon Tyne | Tyne and Wear | 5-9 days |
| Nottingham | Nottinghamshire | 5-9 days |
| Cardiff | Wales | 5-9 days |
| Leicester | Leicestershire | 5-9 days |
| Coventry | West Midlands | 5-9 days |
| Belfast | Northern Ireland | 5-9 days |